Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Annemiek M.E. Walenkamp"'
Autor:
Harm L. Ormel, Carolina P. Schröder, Gabriela G.F. van der Schoot, Nico-Derk L. Westerink, Annette W.G. van der Velden, Boelo Poppema, Aline H. Vrieling, Jourik A. Gietema, Annemiek M.E. Walenkamp, Anna K.L. Reyners
Publikováno v:
Breast, Vol 58, Iss , Pp 138-146 (2021)
Background: Adjuvant endocrine therapy (ET) in patients with breast cancer (BC) increases the risk of becoming less physically active. Physical inactivity is associated with a higher risk of treatment-related side effects and mortality. This study in
Externí odkaz:
https://doaj.org/article/547d7b020d7545e0b5316c4e5e928e98
Autor:
Urszula M. Domanska, Hetty Timmer-Bosscha, Wouter B. Nagengast, Thijs H. Oude Munnink, Roeliene C. Kruizinga, Hildo J.K. Ananias, Nathalie M. Kliphuis, Gerwin Huls, Elisabeth G.E. De Vries, Igle J. de Jong, Annemiek M.E. Walenkamp
Publikováno v:
Neoplasia: An International Journal for Oncology Research, Vol 14, Iss 8, Pp 709-718 (2012)
Several in vitro and in vivo models have revealed the key role of CXCR4/CXCL12 axis in tumor-stroma interactions. Stromal cells present in the tumor microenvironment express high levels of CXCL12 protein, directly stimulating proliferation and migrat
Externí odkaz:
https://doaj.org/article/10a520abfb254546adf422424a61936d
Autor:
Annemiek M.E. Walenkamp, Ingrid G.J. Boer, Jovanka Bestebroer, Dennie Rozeveld, Hetty Timmer-Bosscha, Wieger Hemrika, Jos A.G. van Strijp, Carla J.C. de Haas
Publikováno v:
Neoplasia: An International Journal for Oncology Research, Vol 11, Iss 4, Pp 333-344 (2009)
Purpose: Tumor cell migration and metastasis share many similarities with leukocyte trafficking, which is critically regulated by chemokines and their receptors. CXCR4 is the most widely expressed chemokine receptor in many different types of cancer
Externí odkaz:
https://doaj.org/article/cef2c064f4174eba96525fcfb8d8138f
Autor:
Eske Christiane Gertje, MD, Annemiek M.E. Walenkamp, MD, PhD, Andor W.J.M. Glaudemans, MD, Sander A.J.C. Ijtsma, MD, Klaas Hoogenberg, MD, PhD, Robin P.F. Dullaart, MD, PhD
Publikováno v:
AACE Clinical Case Reports, Vol 1, Iss 4, Pp e230-e239 (2015)
ABSTRACT: Objective: Insulinomas are insulin-producing neuroendocrine tumors. Insulinomas presenting during pregnancy and the early postpartum period are very rare.Methods: A 33-year-old woman with hypoglycemia early postpartum is described. Abdomina
Externí odkaz:
https://doaj.org/article/019e5dd9c90a414db6bc879008591a30
Autor:
Gabriela G.F. van der Schoot, Harm L. Ormel, Nico-Derk L. Westerink, Anne M. May, Sjoerd G. Elias, Yoran M. Hummel, Joop D. Lefrandt, Peter van der Meer, Joost P. van Melle, Boelo J. Poppema, Joyce M.A. Stel, Annette W.G. van der Velden, Aline H. Vrieling, Johan B. Wempe, Marcel G. ten Wolde, Marcel Nijland, Elisabeth G.E. de Vries, Jourik A. Gietema, Annemiek M.E. Walenkamp
Publikováno v:
JACC: CardioOncology. 4:491-503
Autor:
Willeke R. Naaktgeboren, Wim G. Groen, Judy N. Jacobse, Lars C. Steggink, Annemiek M.E. Walenkamp, Wim H. van Harten, Martijn M. Stuiver, Neil K. Aaronson, Berthe M.P. Aleman, Peter van der Meer, Michael Schaapveld, Gabe S. Sonke, Jourik A. Gietema, Flora E. van Leeuwen, Anne M. May
Publikováno v:
JACC: CardioOncology. 4:183-191
Autor:
Morten Mau-Sørensen, Sharon Shacham, Michael G. Kauffman, Yosef Landesman, Andrea Califano, Mariano J. Alvarez, Yao Shen, Leah Henegar, Sharon Tamir, Hua Chang, Christopher J. Walker, Kai Li, Adam L. Green, Annemiek M.E. Walenkamp, Scott R. Plotkin, Martin J. van den Bent, Patrick Y. Wen, Andrew B. Lassman
Purpose:Selinexor is an oral selective inhibitor of exportin-1 (XPO1) with efficacy in various solid and hematologic tumors. We assessed intratumoral penetration, safety, and efficacy of selinexor monotherapy for recurrent glioblastoma.Patients and M
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::192159fde224779091c71357b6b6686d
https://doi.org/10.1158/1078-0432.c.6530990
https://doi.org/10.1158/1078-0432.c.6530990
Autor:
Morten Mau-Sørensen, Sharon Shacham, Michael G. Kauffman, Yosef Landesman, Andrea Califano, Mariano J. Alvarez, Yao Shen, Leah Henegar, Sharon Tamir, Hua Chang, Christopher J. Walker, Kai Li, Adam L. Green, Annemiek M.E. Walenkamp, Scott R. Plotkin, Martin J. van den Bent, Patrick Y. Wen, Andrew B. Lassman
Supplementary Data from A Phase II Study of the Efficacy and Safety of Oral Selinexor in Recurrent Glioblastoma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::af5534528cbfdc66fba19e506a827076
https://doi.org/10.1158/1078-0432.22482734.v1
https://doi.org/10.1158/1078-0432.22482734.v1
Autor:
Iris N. Poleé, Bregtje C.M. Hermans, Jan Maarten van der Zwan, Stefan A.W. Bouwense, Marcus W. Dercksen, Ferry A.L.M. Eskens, Bastiaan Havekes, Johannes Hofland, Thomas M.A. Kerkhofs, Heinz-Josef Klümpen, Loes M. Latten-Jansen, Ernst-Jan M. Speel, Frederik A. Verburg, Annemiek M.E. Walenkamp, Sandra M.E. Geurts, Judith de Vos-Geelen
Publikováno v:
European Journal of Cancer, 172, 252-263. Pergamon
European Journal of Cancer, 172, 252-263. Elsevier Ltd.
Poleé, I N, Hermans, B C M, van der Zwan, J M, Bouwense, S A W, Dercksen, M W, Eskens, F A L M, Havekes, B, Hofland, J, Kerkhofs, T M A, Klümpen, H-J, Latten-Jansen, L M, Speel, E-J M, Verburg, F A, Walenkamp, A M E, Geurts, S M E & de Vos-Geelen, J 2022, ' Long-term survival in patients with gastroenteropancreatic neuroendocrine neoplasms : A population-based study ', European Journal of Cancer, vol. 172, pp. 252-263 . https://doi.org/10.1016/j.ejca.2022.06.003
European Journal of Cancer, 172, 252-263. Elsevier Limited
European Journal of Cancer, 172, 252-263. ELSEVIER SCI LTD
European Journal of Cancer, 172, 252-263. Elsevier Ltd.
Poleé, I N, Hermans, B C M, van der Zwan, J M, Bouwense, S A W, Dercksen, M W, Eskens, F A L M, Havekes, B, Hofland, J, Kerkhofs, T M A, Klümpen, H-J, Latten-Jansen, L M, Speel, E-J M, Verburg, F A, Walenkamp, A M E, Geurts, S M E & de Vos-Geelen, J 2022, ' Long-term survival in patients with gastroenteropancreatic neuroendocrine neoplasms : A population-based study ', European Journal of Cancer, vol. 172, pp. 252-263 . https://doi.org/10.1016/j.ejca.2022.06.003
European Journal of Cancer, 172, 252-263. Elsevier Limited
European Journal of Cancer, 172, 252-263. ELSEVIER SCI LTD
BACKGROUND: Gastroenteropancreatic (GEP) neuroendocrine neoplasms (NENs) comprise a group of rare malignant tumours with heterogeneous behaviour. This study aimed to assess long-term survival and prognostic factors associated with survival, in order
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::607569cfb86f133c9da776b144b0662b
https://research.vumc.nl/en/publications/d83ad8cc-66a1-4e3d-8ece-b7d3abc59107
https://research.vumc.nl/en/publications/d83ad8cc-66a1-4e3d-8ece-b7d3abc59107
Autor:
Frederick S. Varn, Kevin C. Johnson, Jan Martinek, Jason T. Huse, MacLean P. Nasrallah, Pieter Wesseling, Lee A.D. Cooper, Tathiane M. Malta, Taylor E. Wade, Thais S. Sabedot, Daniel Brat, Peter V. Gould, Adelheid Wöehrer, Kenneth Aldape, Azzam Ismail, Santhosh K. Sivajothi, Floris P. Barthel, Hoon Kim, Emre Kocakavuk, Nazia Ahmed, Kieron White, Indrani Datta, Hyo-Eun Moon, Steven Pollock, Christine Goldfarb, Ga-Hyun Lee, Luciano Garofano, Kevin J. Anderson, Djamel Nehar-Belaid, Jill S. Barnholtz-Sloan, Spyridon Bakas, Annette T. Byrne, Fulvio D’Angelo, Hui K. Gan, Mustafa Khasraw, Simona Migliozzi, D. Ryan Ormond, Sun Ha Paek, Erwin G. Van Meir, Annemiek M.E. Walenkamp, Colin Watts, Tobias Weiss, Michael Weller, Karolina Palucka, Lucy F. Stead, Laila M. Poisson, Houtan Noushmehr, Antonio Iavarone, Roel G.W. Verhaak, Kristin D. Alfaro, Samirkumar B. Amin, David M. Ashley, Christoph Bock, Andrew Brodbelt, Ketan R. Bulsara, Ana Valeria Castro, Jennifer M. Connelly, Joseph F. Costello, John F. de Groot, Gaetano Finocchiaro, Pim J. French, Anna Golebiewska, Ann C. Hau, Chibo Hong, Craig Horbinski, Kasthuri S. Kannan, Mathilde CM. Kouwenhoven, Anna Lasorella, Peter S. LaViolette, Keith L. Ligon, Allison K. Lowman, Shwetal Mehta, Hrvoje Miletic, Annette M. Molinaro, Ho Keung Ng, Simone P. Niclou, Johanna M. Niers, Joanna J. Phillips, Raul Rabadan, Ganesh Rao, Guido Reifenberger, Nader Sanai, Susan C. Short, Peter Sillevis Smitt, Andrew E. Sloan, Marion Smits, James M. Snyder, Hiromichi Suzuki, Ghazaleh Tabatabai, Georgette Tanner, William H. Tomaszewski, Michael Wells, Bart A. Westerman, Helen Wheeler, Jichun Xie, W.K. Alfred Yung, Gelareh Zadeh, Junfei Zhao, Roel GW. Verhaak
Publikováno v:
Cell, 185(12), 2184-2199.e16. Cell Press
Cell
Cell, vol 185, iss 12
The GLASS Consortium 2022, ' Glioma progression is shaped by genetic evolution and microenvironment interactions ', Cell, vol. 185, no. 12, pp. 2184-2199.e16 . https://doi.org/10.1016/j.cell.2022.04.038
Cell, 185(12), 2184-2199.e16. CELL PRESS
Cell
Cell, vol 185, iss 12
The GLASS Consortium 2022, ' Glioma progression is shaped by genetic evolution and microenvironment interactions ', Cell, vol. 185, no. 12, pp. 2184-2199.e16 . https://doi.org/10.1016/j.cell.2022.04.038
Cell, 185(12), 2184-2199.e16. CELL PRESS
The factors driving therapy resistance in diffuse glioma remain poorly understood. To identify treatment-associated cellular and genetic changes, we analyzed RNA and/or DNA sequencing data from the temporally separated tumor pairs of 304 adult patien
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::36aa8231290284197e37208bfab4dbba
https://research.vumc.nl/en/publications/312bbb0a-1328-4405-bfbe-cce4f07b8a67
https://research.vumc.nl/en/publications/312bbb0a-1328-4405-bfbe-cce4f07b8a67